Advanced Neuromodulation Systems's Chavez stunned by HHS (Health and Human Services) subpoena
This article was originally published in Clinica
Advanced Neuromodulation Systems (ANS), the Dallas, Texas developer of implantable neural stimulation devices, has received a subpoena from the Inspector General at the US Department of Health and Human Services (HHS). The documents requested relate to the company's sales and marketing, reimbursement, Medicare and Medicaid billing and certain other business practices.
You may also be interested in...
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.
UK-based charity International Health Partners has launched a fresh appeal to double the value funds being raised to send essential medicines to expectant mothers and children at risk of death in areas of extreme deprivation.